Jason S Fisherman - Net Worth and Insider Trading
Jason S Fisherman Net Worth
The estimated net worth of Jason S Fisherman is at least $615,910 dollars as of 2024-11-13. Jason S Fisherman is the Director of Achillion Pharmaceuticals Inc and owns about 50,000 shares of Achillion Pharmaceuticals Inc (ACHN) stock worth over $338,000. Jason S Fisherman is the Director of Exelixis Inc and owns about 7,881 shares of Exelixis Inc (EXEL) stock worth over $277,884. Jason S Fisherman is also the Director of Aegerion Pharmaceuticals Inc and owns about 13 shares of Aegerion Pharmaceuticals Inc (AEGR) stock worth over $26. Details can be seen in Jason S Fisherman's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Jason S Fisherman has not made any transactions after 2016-12-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Jason S Fisherman
Jason S Fisherman Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Jason S Fisherman owns 4 companies in total, including Achillion Pharmaceuticals Inc (ACHN) , Aegerion Pharmaceuticals Inc (AEGR) , and Raptor Pharmaceutical Corp (RPTP) among others .
Click here to see the complete history of Jason S Fisherman’s form 4 insider trades.
Insider Ownership Summary of Jason S Fisherman
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2020-01-28 | director |
| AEGR | Aegerion Pharmaceuticals Inc | 2010-10-27 | director |
| RPTP | Raptor Pharmaceutical Corp | 2008-06-19 | director |
 | | 2005-09-08 | director |
Jason S Fisherman Latest Holdings Summary
Jason S Fisherman currently owns a total of 3 stocks. Among these stocks, Jason S Fisherman owns 50,000 shares of Achillion Pharmaceuticals Inc (ACHN) as of December 22, 2016, with a value of $338,000 and a weighting of 54.88%. Jason S Fisherman owns 7,881 shares of Exelixis Inc (EXEL) as of September 8, 2005, with a value of $277,884 and a weighting of 45.12%. Jason S Fisherman also owns 13 shares of Aegerion Pharmaceuticals Inc (AEGR) as of October 21, 2010, with a value of $26 and a weighting of 0%.
Latest Holdings of Jason S Fisherman
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACHN | Achillion Pharmaceuticals Inc | 2016-12-22 | 50,000 | 6.76 | 338,000 |
| EXEL | Exelixis Inc | 2005-09-08 | 7,881 | 35.26 | 277,884 |
| AEGR | Aegerion Pharmaceuticals Inc | 2010-10-21 | 13 | 1.97 | 26 |
Holding Weightings of Jason S Fisherman
Jason S Fisherman Form 4 Trading Tracker
According to the SEC Form 4 filings, Jason S Fisherman has made a total of 0 transactions in Achillion Pharmaceuticals Inc (ACHN) over the past 5 years. The most-recent trade in Achillion Pharmaceuticals Inc is the acquisition of 10,000 shares on December 22, 2016, which cost Jason S Fisherman around $39,600.
According to the SEC Form 4 filings, Jason S Fisherman has made a total of 0 transactions in Exelixis Inc (EXEL) over the past 5 years. The most-recent trade in Exelixis Inc is the sale of 986 shares on September 8, 2005, which brought Jason S Fisherman around $7,760.
According to the SEC Form 4 filings, Jason S Fisherman has made a total of 0 transactions in Aegerion Pharmaceuticals Inc (AEGR) over the past 5 years. The most-recent trade in Aegerion Pharmaceuticals Inc is the sale of 0 shares on October 21, 2010, which brought Jason S Fisherman around $0.
Insider Trading History of Jason S Fisherman
- 1
Jason S Fisherman Trading Performance
GuruFocus tracks the stock performance after each of Jason S Fisherman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jason S Fisherman is -10.4%. GuruFocus also compares Jason S Fisherman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jason S Fisherman within 3 months outperforms 1 times out of 5 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Jason S Fisherman's insider trading performs compared to the benchmark.
Performance of Jason S Fisherman
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 0.41 | | | | | |
| Relative Return to S&P 500(%) | -0.91 | | | | | |
Jason S Fisherman Ownership Network
Ownership Network List of Jason S Fisherman
Ownership Network Relation of Jason S Fisherman
Jason S Fisherman Owned Company Details
What does Achillion Pharmaceuticals Inc do?
Who are the key executives at Achillion Pharmaceuticals Inc?
Jason S Fisherman is the director of Achillion Pharmaceuticals Inc. Other key executives at Achillion Pharmaceuticals Inc include EVP & Chief Commercial Officer Paul E Firuta , EVP & Chief Medical Officer Steven Zelenkofske , and General Counsel Martha E Manning .
Achillion Pharmaceuticals Inc (ACHN) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Achillion Pharmaceuticals Inc (ACHN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Achillion Pharmaceuticals Inc (ACHN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Achillion Pharmaceuticals Inc (ACHN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Achillion Pharmaceuticals Inc Insider Transactions
Jason S Fisherman Mailing Address
Above is the net worth, insider trading, and ownership report for Jason S Fisherman. You might contact Jason S Fisherman via mailing address: C/o Advent International Corp, 75 State St 29th Floor, Boston Ma 02104.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
